Literature DB >> 19230849

TNF superfamily: costimulation and clinical applications.

Dass S Vinay1, Byoung S Kwon.   

Abstract

The molecules concerned with costimulation belong either to the immunoglobulin (Ig) or tumor necrosis factor (TNF) superfamily. The tumor necrosis superfamily comprises molecules capable of providing both costimulation and cell death. In this review we briefly summarize certain TNF superfamily receptor-ligand pairs that are endowed with costimulatory properties and their importance in health and disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19230849      PMCID： PMC2712666          DOI： 10.1016/j.cellbi.2009.02.001

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN： 1065-6995            Impact factor:   3.612


  167 in total

1.  LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Authors:  K Tamada; K Shimozaki; A I Chapoval; Y Zhai; J Su; S F Chen; S L Hsieh; S Nagata; J Ni; L Chen
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand.

Authors:  B Kwon; K Y Yu; J Ni; G L Yu; I K Jang; Y J Kim; L Xing; D Liu; S X Wang; B S Kwon
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

Review 3.  CD27 and CD70 in T cell and B cell activation.

Authors:  Jannie Borst; Jenny Hendriks; Yanling Xiao
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

4.  CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.

Authors:  S Y Lee; S Y Lee; G Kandala; M L Liou; H C Liou; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

5.  CD27 and (TNFR) relatives in the immune system: their role in health and disease.

Authors:  W A Loenen
Journal:  Semin Immunol       Date:  1998-12       Impact factor: 11.130

6.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

7.  Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Authors:  R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

8.  The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.

Authors:  I A Rooney; K D Butrovich; A A Glass; S Borboroglu; C A Benedict; J C Whitbeck; G H Cohen; R J Eisenberg; C F Ware
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

9.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Authors:  C A Smith; H J Gruss; T Davis; D Anderson; T Farrah; E Baker; G R Sutherland; C I Brannan; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

10.  Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.

Authors:  Stefanie Scheu; Judith Alferink; Tobias Pötzel; Winfried Barchet; Ulrich Kalinke; Klaus Pfeffer
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307
View more
  9 in total

Review 1.  The TNF family in T cell differentiation and function--unanswered questions and future directions.

Authors:  Michael Croft
Journal:  Semin Immunol       Date:  2014-03-06       Impact factor: 11.130

2.  Cobra CRISP functions as an inflammatory modulator via a novel Zn2+- and heparan sulfate-dependent transcriptional regulation of endothelial cell adhesion molecules.

Authors:  Yu-Ling Wang; Je-Hung Kuo; Shao-Chen Lee; Jai-Shin Liu; Yin-Cheng Hsieh; Yu-Tsung Shih; Chun-Jung Chen; Jeng-Jiann Chiu; Wen-Guey Wu
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 3.  Inflammation, immunity, and hypertension.

Authors:  David G Harrison; Tomasz J Guzik; Heinrich E Lob; Meena S Madhur; Paul J Marvar; Salim R Thabet; Antony Vinh; Cornelia M Weyand
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

4.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

Review 5.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 6.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

7.  Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer.

Authors:  Zhihui Zhang; Peng Wu; Chaoqi Zhang; Yuejun Luo; Guochao Zhang; Qingpeng Zeng; Lide Wang; Zhaoyang Yang; Nan Sun; Jie He
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

8.  Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.

Authors:  Edwin Bremer
Journal:  ISRN Oncol       Date:  2013-06-11

Review 9.  4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  BMB Rep       Date:  2014-03       Impact factor: 4.778
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.